Dioctyl Terephthalate (DOTP) Toxicity Assessment: Testing Standards, Safety Evaluation, and Regulato

Dioctyl Terephthalate (DOTP), also known as bis(2-ethylhexyl) terephthalate (DEHT), is a high-molecular-weight terephthalate plasticizer widely adopted as a safer alternative to restricted ortho-phthalates such as DEHP. A comprehensive DOTP toxicity assessment combines analytical quantification, in vitro and in vivo toxicological testing, and migration and exposure evaluation to demonstrate product safety and regulatory compliance in toys, medical devices, food contact materials, and flexible PVC applications. This article explains the toxicological profile of DOTP, the applicable international testing standards, and the methodologies used by accredited third-party laboratories to verify its safety.

Technical Overview

Dioctyl Terephthalate (DOTP; CAS No. 6422-86-2), chemically named bis(2-ethylhexyl) terephthalate (DEHT), is a general-purpose plasticizer with the molecular formula C24H38O4 and a molecular weight of 390.57 g/mol. It is a colorless to pale yellow, oily liquid with low volatility, high compatibility with PVC, and excellent resistance to extraction and volatilization. Structurally, DOTP is the para (1,4-) isomer of di-2-ethylhexyl phthalate (DEHP), and this positional difference in the ester groups on the benzene ring produces a markedly different toxicological behavior.

The toxicological profile of DOTP has been extensively evaluated in regulatory and academic studies. The key findings are summarized below:

• Low acute toxicity: reported oral LD50 values in rats exceed 5000 mg/kg body weight, classifying DOTP as practically non-toxic by the acute oral route.
• No skin sensitization potential in validated animal and in vitro assays, and at most mild, reversible skin and eye irritation.
• Negative results in standard genotoxicity batteries, including bacterial reverse mutation assays and in vitro and in vivo chromosomal aberration and micronucleus tests.
• No classification for carcinogenicity, mutagenicity, or reproductive toxicity (CMR) under the EU Classification, Labelling and Packaging (CLP) Regulation.
• Not included on the EU REACH Candidate List of Substances of Very High Concern (SVHC) and not restricted under REACH Annex XVII entries 51 and 52, which apply to DEHP, DBP, BBP, and DIBP.
• The primary metabolite, mono(2-ethylhexyl) terephthalate (MEHT), shows substantially weaker peroxisome proliferator-activated receptor (PPAR) activation and negligible anti-androgenic activity compared with MEHP, the active metabolite of DEHP.

A rigorous toxicity assessment therefore focuses on confirming product purity, quantifying migration under realistic use conditions, and generating or verifying endpoint data in accordance with internationally recognized test guidelines.

Testing Samples

Raw DOTP Substance and Technical-Grade Material

Pure or technical-grade DOTP is tested for identity confirmation, purity, and impurity profiling, including residual ortho-phthalates (such as DEHP), residual monomers, catalysts, and low-molecular-weight by-products from the esterification process. Raw material characterization forms the foundation of any downstream risk assessment.

Plasticized PVC Compounds and Masterbatches

Pellets, granules, plastisols, and compound formulations containing DOTP are analyzed to verify plasticizer content, homogeneity of dispersion, and conformity with formulation declarations before conversion into finished goods.

Finished Products and Articles

End-use articles such as toys and childcare products, medical device components, wire and cable insulation, flooring, synthetic leather, films, and coated fabrics are tested for total DOTP content and, where applicable, migratable fractions.

Extracts, Leachates, and Migration Solutions

Aqueous extracts, saliva simulants, sweat simulants, and food simulants generated under standardized migration conditions are used for cytotoxicity, sensitization, irritation, and systemic toxicity evaluations, particularly for medical devices and items with prolonged skin or oral contact.

Testing Items

A complete DOTP toxicity assessment typically encompasses the following categories of test items:

• Identity and purity confirmation: Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR), gas chromatography (GC), and mass spectrometry (MS).
• Acute toxicity: acute oral, dermal, and inhalation toxicity; skin corrosion and irritation; eye irritation; skin sensitization.
• Repeated-dose toxicity: 28-day and 90-day subchronic studies with establishment of NOAEL and LOAEL values.
• Genotoxicity: bacterial reverse mutation (Ames) test, in vitro mammalian chromosomal aberration test, in vitro and in vivo micronucleus tests, and gene mutation assays.
• Reproductive and developmental toxicity: prenatal developmental toxicity screening and reproductive screening studies.
• Endocrine activity screening: estrogenic, androgenic, and thyroid-related in vitro assays and confirmatory in vivo screening where triggered.
• Content and migration quantification: total DOTP content in polymer matrices and migration into saliva, sweat, and food simulants.
• Impurity screening: cross-contamination with regulated ortho-phthalates (DEHP, DBP, BBP, DIBP, DINP, DIDP, DNOP) and other restricted plasticizers.
• Ecotoxicology: ready biodegradability, acute and chronic aquatic toxicity, and bioaccumulation potential.

Testing Methods

Analytical Identification and Quantification

DOTP content in polymers and finished articles is determined by gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS) following solvent extraction. Relevant method frameworks include IEC 62321-8 for the determination of phthalates in polymeric materials, ISO 8124-6 for phthalate esters in toys and children's products, EN 14372 for child use and care articles, GB/T 22048 for plasticized materials in toys, and ASTM F963 toy safety provisions referencing phthalate limits. Quantification limits are typically established at or below 0.01 percent (100 mg/kg) to support 0.1 percent regulatory thresholds.

Migration and Exposure Testing

Migration testing simulates realistic contact scenarios. Toys and childcare articles are assessed using saliva simulants under EN 71 series procedures, while food contact materials are evaluated for overall and specific migration using food simulants in accordance with EN 1186, EN 13130, the GB 31604 series, and EU Regulation (EU) No 10/2011 requirements. Derived migration values are combined with product-use parameters to estimate exposure doses for comparison with health-based guidance values such as tolerable daily intake (TDI).

In Vitro Toxicity Testing

In vitro endpoints are conducted under OECD test guidelines and Good Laboratory Practice (GLP), including the bacterial reverse mutation test (OECD TG 471), in vitro mammalian chromosomal aberration test (OECD TG 473), in vitro mammalian cell gene mutation test (OECD TG 476), in vitro micronucleus test (OECD TG 487), reconstructed human epidermis skin corrosion and irritation methods (OECD TG 431 and TG 439), and defined-approach skin sensitization assays (OECD TG 442 series). Cytotoxicity of medical device extracts is evaluated using ISO 10993-5.

In Vivo Toxicity Testing

Where animal studies are scientifically justified and ethically required, protocols follow OECD guidelines such as acute oral toxicity (OECD TG 420 or TG 423), repeated-dose 90-day oral toxicity (OECD TG 408), prenatal developmental toxicity (OECD TG 414), reproductive and developmental screening (OECD TG 421 and TG 422), local lymph node assay for sensitization (OECD TG 429), uterotrophic and Hershberger endocrine screening (OECD TG 440 and TG 441), and the in vivo mammalian micronucleus test (OECD TG 474). All studies are designed according to the 3Rs principles of replacement, reduction, and refinement.

Medical Device Biocompatibility Evaluation

For DOTP-plasticized medical device components, biological evaluation is performed under the ISO 10993 series, including ISO 10993-1 for the evaluation and testing framework, ISO 10993-3 for genotoxicity, ISO 10993-5 for cytotoxicity, ISO 10993-10 for sensitization, ISO 10993-11 for systemic toxicity, and ISO 10993-23 for irritation. A chemical toxicity assessment of extractables and leachables, including DOTP itself, is integral to the ISO 10993-17 tolerable exposure evaluation.

Environmental Fate and Ecotoxicology

Environmental endpoints include ready biodegradability (OECD TG 301 series), acute toxicity to fish, daphnia, and algae (OECD TG 203, TG 202, and TG 201), chronic aquatic studies where triggered, and bioconcentration assessment (OECD TG 305), supporting environmental risk characterization under REACH and comparable frameworks.

Applications

DOTP is selected across industries where plasticizer safety, low migration, and regulatory acceptance are essential. Typical applications supported by toxicity assessment data include:

• Toys, childcare articles, and baby care products requiring phthalate-free compliance and low-migration validation.
• Medical devices such as intravenous bags, infusion tubing, blood bags, and catheters, where biocompatibility and extractables/leachables evaluation are mandatory.
• Food contact materials, including films, gaskets, seals, and closures, subject to migration limits under EU and GB food contact regulations.
• Wire and cable insulation and jacketing compounds compliant with EU RoHS, which restricts DEHP, DBP, BBP, and DIBP but not DOTP.
• Flooring, wall coverings, synthetic leather, and coated textiles for buildings and vehicles.
• Adhesives, sealants, inks, and polymer modifiers where a low-toxicity plasticizer is specified.

FAQ

Is DOTP toxic to humans?

Based on the available toxicological database, DOTP exhibits low acute toxicity, is not a skin sensitizer, is not genotoxic, and does not meet the criteria for classification as carcinogenic, mutagenic, or toxic to reproduction. Regulatory evaluations in the EU have concluded that classification for fertility or developmental effects is not warranted, and DOTP is not listed as an SVHC under REACH.

Is DOTP considered a phthalate under current regulations?

Chemically, DOTP is a terephthalate (para-phthalate) ester. In regulatory practice, restrictions targeting phthalates apply specifically to ortho-phthalates such as DEHP, DBP, BBP, and DIBP. DOTP is not among the phthalates restricted by EU RoHS, EU REACH Annex XVII entries 51 and 52, or the United States CPSIA phthalate limits, which is why it is commonly marketed as a phthalate-free alternative.

How does DOTP compare with DEHP in terms of safety?

Although DOTP and DEHP share the same ester side chains, the para orientation of the ester groups in DOTP changes its metabolism significantly. The primary metabolite MEHT shows weak PPAR activation and negligible anti-androgenic activity, whereas MEHP, the metabolite of DEHP, is associated with testicular toxicity and endocrine-mediated developmental effects. This mechanistic difference underpins the more favorable safety profile of DOTP.

Can DOTP be used in toys, medical devices, and food contact materials?

Yes. DOTP is widely used in these sensitive applications, provided that product-specific requirements are met: phthalate content and migration limits for toys, biocompatibility under the ISO 10993 series for medical devices, and migration compliance under applicable EU, GB, and national food contact regulations for food contact materials.

Why is impurity screening important in a DOTP toxicity assessment?

Manufacturing processes and shared production equipment can introduce regulated ortho-phthalates such as DEHP as impurities or cross-contaminants. Screening for these substances is essential to verify phthalate-free claims, to confirm compliance with 0.1 percent restriction thresholds, and to exclude confounding toxicological contributions from unintended impurities.

What reports and deliverables are provided after testing?

Accredited third-party laboratories typically deliver test reports covering analytical quantification, migration results, toxicological endpoint summaries, exposure and risk characterization, and conformity conclusions against the applicable regulations. These reports support regulatory submissions, customer declarations, eco-label applications, and internal product safety documentation.